Stefan Berg – General Manager, Pharmaplan AG Switzerland
Stefan Berg, general manager of Pharmaplan, one of the leading pharma engineering partners in Europe, outlines the key trends in this area, including an expected investment boom in the coming…
Address: No. 106
16th Road
Midrand
Johannesburg
,South Africa
Tel: +27 (0)87 742 1860
Web: http://www.pharmaplan.co.za/
Pharmaplan Pty Ltd is a fast growing pharmaceutical company that represents small to medium sized international Principals in South Africa and other selected Sub Saharan territories.
Pharmaplan is organized to function as a “virtual subsidiary” for its partners by assigning dedicated marketing and sales teams by Principal, whilst sharing the non-strategic functions such as order processing, administration, warehousing and distribution.
Pharmaplan works with its International Partners on an arm’s length basis and takes care of all aspects of the business from registration, marketing and sales, to distribution and collection of payments.
Pharmaplan (Pty) Ltd has been registered as an importer and distributor of niche’ speciality/biotechnology medicines since 1996. Pharmaplan is a fully fledged pharmaceutical company, approved by the Pharmacy Council and Medicines Control Council to hold Registration Licences, providing the full spectrum of services from Registration, Regulatory, Marketing and Sales to Distribution (including cold chain).
At Pharmaplan, we represent many prominent international companies as their ‘virtual subsidiary’.Pharmaplan registers and markets the products of selected overseas principals either on its own behalf or manages the complete set up of true local subsidiaries.
Therapeutic areas of expertise include oncology, dermatology, nephrology, paediatrics, gynecology, surgery, radiology, neurology, cardiology and Psychiatry.
Most principals also entrust Pharmaplan with exports to many Sub Saharan African countries.
Stefan Berg, general manager of Pharmaplan, one of the leading pharma engineering partners in Europe, outlines the key trends in this area, including an expected investment boom in the coming…
The CEO of NNE Pharmaplan, the world’s leading engineering and consultancy focused in the fields of pharma and biotech, unveils the company’s current opportunities and strategy as it spreads its…
One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What were the strategic motivations for establishing a presence…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However,…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
The head of KPMG’s life science division in Africa, Joubert Krugel, discusses the current state of South Africa’s healthcare system, the imminent trends taking place, and how the business community…
Marius Fourie highlights implications of the recent merger between the company’s two subsidiaries and the unparalleled levels of value and service the consolidated organization will offer. He also illustrates the affiliate’s strategies…
See our Cookie Privacy Policy Here
